Glucon Appoints New U.S.-based CEO Mr. Daniel Goldberger

Glucon (www.glucon.com), developer of a continuous, noninvasive, blood glucose monitoring technology for home and clinical use, announced today the appointment of Mr. Daniel Goldberger as the Company’s new CEO.

MORE ON THIS TOPIC